Biotechnology in China – regulation, investment, and delayed commercialization. Issue 1 (31st December 2022)

• Record Type: Journal Article
• Authors: Xiao, Zhihua; Kerr, William A.
• Is Part Of: GM crops and food. Volume 13:Issue 1(2022)
• Page Start: 86
• Page End: 96
• Publication Date: 2022-12-31
• Subjects: China -- commercialization -- GMOs -- regulation -- social cohesion; Crops -- Genetic engineering -- Periodicals; Agriculture -- Periodicals; Food industry and trade -- Periodicals; 631.5233
• DOI: 10.1080/21645698.2022.2068336
• Languages: English
• ISSNs: 2164-5701

Abstract

ABSTRACT: China has been investing heavily in biotechnology to increase agricultural productivity. While a number of Chinese developed GM crops have cleared the required scientific hurdles – some more than a decade ago – commercialization has not been approved. The regulatory regime for GMOs in China is relatively less well understood than that of the US or the EU. This paper provides a systematic overview of China's regulatory regime, R&D investment and delayed commercialization decisions on biotechnology over the last 40 years and draws some conclusions regarding the likelihood of the commercialization for major GM crops in the future.